Repositioning Candidate Details
| Candidate ID: | R1017 |
| Source ID: | DB06447 |
| Source Type: | investigational |
| Compound Type: | small molecule |
| Compound Name: | E5531 |
| Synonyms: | -- |
| Molecular Formula: | C73H136N2O22P2 |
| SMILES: | [H]N([C@H]1[C@@H](OP(O)(O)=O)O[C@H](CO[C@@H]2O[C@H](COC)[C@@H](OP(O)(O)=O)[C@H](OCC[C@@H](CCCCCCC)OC(=O)CCC\C=C/CCCCCC)[C@H]2N([H])C(=O)CC(=O)CCCCCCCCCCC)[C@@H](O)[C@@H]1OCC[C@H](O)CCCCCCC)C(=O)CC(=O)CCCCCCCCCCC |
| Structure: |
|
| DrugBank Description: | E5531 is an endotoxin antagonist. |
| CAS Number: | 162679-36-9 |
| Molecular Weight: | 1455.831 |
| DrugBank Indication: | Investigated for use/treatment in sepsis and septicemia. |
| DrugBank Pharmacology: | -- |
| DrugBank MoA: | -- |
| Targets: | Toll-like receptor 4 |
| Inclusion Criteria: | Target associated |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class |
|---|